Imagine a future where a doctor knows exactly which of one their patients might get sick and when. They would know exactly how sick and be able to prescribe a treatment before any problems occurred quickly. This vision of healthcare may not be too far off thanks to recent advancements in applying artificial intelligence within the space. A recent report from CBinsights outlined more than 90 companies that are using machine learning algorithms and predictive analytics to reduce drug discovery times, provide virtual assistance to patients, and diagnose ailments by processing medical images, among other things. Misdiagnosis by physicians is a grave and common occurrence in the health industry. Every year an estimated 10 percent to 20 percent of cases are misdiagnosed. These misdiagnoses exceed those of drug and surgery errors on the wrong patient or body part, both of which receive considerably more attention. The repercussions of a misdiagnosis can damage a patient’s health, and cost healthcare provides significant amounts of money or even the life of a patie

The role of Artificial Intelligence (AI) as a major catalyst in the healthcare revolution is unquestionable. We are today experiencing the Fourth Industrial Revolution, and the proliferation of technologies that are fusing the physical, digital and biological worlds and thereby impacting global economies and industries is unparalleled.

A handful of startups are employing artificial intelligence technologies and big data in an attempt to diagnose dementia, particularly Alzheimer’s disease. The effort could lead to better interventions and even therapeutic drugs if it becomes possible to detect cognitive decline before it really starts.

Heart disease is one of the leading causes of death worldwide. In the United States, for example, heart disease accounts for 1 in every 4 deaths. In Europe, heart disease accounts for 45 percent of all deaths. Now scientists at the London Institute of Medical Services have created artificial […]Click here to view original web page at www.roboticstrends.com

Let’s take the $3 billion medical imaging market.

Artificial intelligence is everywhere: your smartphone, on streaming platforms such as Spotify and Netflix and even in some smart home appliances. But can the technology, which has seemingly caught the attention of most VCs across the world, be used in the realm of healthcare to drive efficiency and optimise patient outcomes? We take a look at some of the UK’s most promising companies using AI to transform the healthcare space.

The money just keeps flowing in to fund new startups in the healthcare space. In fact, 2016 is already off to a record start with $1.8 billion in funding so far in 2016 Q1, according to StartUp Health. In this golden age of entrepreneurship, it can be hard to keep up with all of the latest companies disrupting healthcare. We asked five intriguing startups that recently participated in Blueprint Health’s Winter 2016 Demo Day to tell us more about their companies, how they are transforming the industry, what they offer, and what they hope to accomplish.

The dramatic drop in the cost of genome sequencing, combined with rapidly evolving artificial intelligence, is moving precision medicine into mainstream healthcare. Sanjay Chikarmane, senior vice president at Illumina, told an briefing at HIMSS17 in Orlando on Monday that the US$100 genome is now in sight. Illumina is an US company focused on genetics sequencing and analysing big data for biological insights.

ORLANDO – 20 Feb 2017: IBM (NYSE: IBM) today at HIMSS17 introduced IBM Watson Imaging Clinical Review — the first cognitive imaging offering from Watson Health — and announced the expansion of the Watson Health medical imaging collaborative to 24 organizations worldwide, adding clinical and industry expertise for the worldwide initiative already tackling eye, brain, breast, heart and related conditions.